iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024

Stock Information for iCad Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About iCad Inc.

iCAD to Participate in the LD Micro Main Event XVII
iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024
iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024
iCAD Reports Financial Results for Second Quarter Ended June 30, 2024 
iCAD to Report Second Quarter 2024 Financial Results on August 13, 2024
iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography
iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference
iCAD Reports Financial Results for First Quarter Ended March 31, 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.